GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Rani Therapeutics
Rani Therapeutics is a biotech company that has developed a unique "robotic" capsule for the oral delivery of biologics. Its stock price is a bet that its revolutionary technology will replace injections for many medications.
Share prices of companies in the market segment - Pharma other
Rani Therapeutics is a biotech company that developed the revolutionary RaniPill robotic capsule for the oral delivery of injectable drugs. We've classified it under "Other Pharmaceuticals." The chart below shows how the market values breakthrough drug delivery technologies.
Broad Market Index - GURU.Markets
Rani Therapeutics is a biopharmaceutical company that developed the RaniPill robotic pill, which allows for the oral administration of injectable medications. Part of the GURU.Markets index, it is revolutionizing drug delivery. The chart below represents the entire market. See how this innovator compares to the overall trend.
Change in the price of a company, segment, and market as a whole per day
RANI - Daily change in the company's share price Rani Therapeutics
Rani Therapeutics Holdings' daily price change reflects the high volatility inherent in biotech companies. The indicator demonstrates sensitivity to news about clinical trials of its "robotic" capsule for oral drug delivery.
Daily change in the price of a set of shares in a market segment - Pharma other
Rani Therapeutics Holdings, Inc. is a biotech company. This chart shows high volatility. A comparison with RANI's performance, with its "robotic" capsule, helps to assess it as a high-risk asset dependent on clinical data.
Daily change in the price of a broad market stock, index - GURU.Markets
Rani Therapeutics has developed a robotic capsule for the oral delivery of biologic drugs. This is a revolutionary technology. The company's shares reflect the high hopes and risks associated with breakthrough technologies, and their high volatility affects the entire market.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Rani Therapeutics
Rani Therapeutics's performance is the story of its revolutionary oral biologics delivery platform. Its 12-month market cap is entirely dependent on clinical trial data for its "robotic pill," RaniPill. Its success could fundamentally change the way drugs like insulin are administered, replacing injections with capsules.
Annual dynamics of market capitalization of the market segment - Pharma other
Rani Therapeutics Holdings is an innovative company that has developed a robotic capsule for the oral delivery of biologic drugs. Its technology has the potential to revolutionize medicine. Its stock price is extremely volatile, reflecting investor confidence in its breakthrough potential rather than its current financial performance.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Rani, with its "robotic" pill, is one of the most futuristic stories in medicine. Its stock price is completely unrelated to the economy. Its price chart reflects investors' faith in its revolutionary technology becoming a reality, and the price of that faith is extremely volatile.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Rani Therapeutics
Rani Therapeutics is developing a "robotic" capsule for the oral delivery of biologic drugs. Being in the clinical stage, its monthly evaluation is entirely dependent on news releases. Trial results confirming the viability of its unique technology are the main driver.
Monthly dynamics of market capitalization of the market segment - Pharma other
Rani Therapeutics has developed a robotic pill (RaniPill) for the oral delivery of biologic drugs, currently administered only by injection. This is a revolutionary technology. The chart below shows how investors assessed the prospects of breakthrough drug delivery platforms that could change the lives of millions of patients.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Rani Therapeutics is developing a revolutionary "robotic pill" technology for orally delivering biologic drugs. This is a fundamental science story. The stock's performance depends on the success of this platform's clinical trials, not on general market trends.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Rani Therapeutics
Rani Therapeutics is developing revolutionary "robotic pill" technology for the oral delivery of biologics. The stock's weekly performance is highly volatile, driven by news about clinical trials of this futuristic technology and partnerships with major pharmaceutical companies.
Weekly dynamics of market capitalization of the market segment - Pharma other
Rani Therapeutics is developing revolutionary "robotic pill" technology for the oral delivery of biologics. The stock's weekly performance is highly volatile, driven by news about clinical trials of this futuristic technology and partnerships with major pharmaceutical companies.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Rani, a biotech company, lives in a world of its own. Its performance is driven by news about its unique technology. A chart comparing the stock to the S&P 500 clearly demonstrates how the stock can rise or fall on company-specific events, completely ignoring the market.
Market capitalization of the company, segment and market as a whole
RANI - Market capitalization of the company Rani Therapeutics
Rani Therapeutics' market capitalization is a futuristic story about the development of a "robot pill" capable of delivering biologic drugs (such as insulin) orally. The company's price reflects investors' faith in this revolutionary technology. Its volatility reflects the company's reaction to trial data that could change the pharmaceutical industry.
RANI - Share of the company's market capitalization Rani Therapeutics within the market segment - Pharma other
Rani Therapeutics is a biotech company that has developed a robotic capsule for the oral delivery of biologic drugs (such as insulin) that typically require injections. Its share of its segment's market capitalization reflects the breakthrough potential of this technology. The chart below shows the valuation volatility.
Market capitalization of the market segment - Pharma other
Rani Therapeutics has developed a robotic pill, "RaniPill," that delivers biologic drugs (such as insulin) orally. The chart below shows the overall market capitalization of the pharmaceutical sector, reflecting the potential of this breakthrough technology, which could change the way many medications are taken.
Market capitalization of all companies included in a broad market index - GURU.Markets
This graph represents a revolution in drug delivery. Rani Therapeutics has developed a "robotic pill" that can deliver biologic drugs like insulin directly into the intestinal wall. Its line is a bet that this technology will make injections unnecessary for millions of patients.
Book value capitalization of the company, segment and market as a whole
RANI - Book value capitalization of the company Rani Therapeutics
Rani Therapeutics' book value is derived from its unique RaniPill™ "robotic pill" technology, designed for the oral delivery of biologics. This represents revolutionary scientific capital. The chart shows how the company accumulates and expends vast resources on clinical trials and commercialization of its breakthrough platform.
RANI - Share of the company's book capitalization Rani Therapeutics within the market segment - Pharma other
Rani Therapeutics is a company that has developed a robotic capsule for the oral delivery of biologic drugs. Its assets include the manufacturing facilities for creating these complex devices. The chart shows the company's share of this unique medical infrastructure.
Market segment balance sheet capitalization - Pharma other
Developing drug delivery systems, as the BCap_Ges chart for biotech shows, is knowledge-intensive. Rani Therapeutics, with its innovative "robo-pill," must invest heavily in R&D and precision manufacturing, making it capital-intensive in its niche.
Book value of all companies included in the broad market index - GURU.Markets
Rani Therapeutics' assets include capital and unique technology for creating "robotized pills" capable of delivering injectable drugs orally. The book value reflects the financial and scientific basis for creating a revolutionary physical product that will change the way drugs are delivered.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Rani Therapeutics
Rani Therapeutics has developed a unique "robotic" pill for delivering biologic drugs (typically administered by injection). The value lies in this revolutionary platform. The MvsBCap chart will show a significant premium for this potential pharmaceutical breakthrough, and its dynamics will depend on clinical trial data.
Market to book capitalization ratio in a market segment - Pharma other
Rani Therapeutics has developed a robotic capsule for the oral delivery of biologic drugs. Its pricing is based on this breakthrough technology. The chart demonstrates the high expectations of investors for the future of this platform.
Market to book capitalization ratio for the market as a whole
Rani Therapeutics has developed a unique "robotic pill" technology for the oral delivery of biologic drugs (such as insulin). This represents a breakthrough in pharmaceuticals. Its market valuation reflects the enormous potential of this platform. The chart shows how investors value technologies that could change the way we take medications.
Debts of the company, segment and market as a whole
RANI - Company debts Rani Therapeutics
Rani Therapeutics, a biotech company that has developed a unique "robotic" capsule for the oral delivery of biologics, is using capital to conduct clinical trials of its platform. This breakthrough technology requires significant investment. This chart shows how the company is funding its mission to eliminate the need for injections.
Market segment debts - Pharma other
Rani Therapeutics has developed a unique "robotic pill" technology for the oral delivery of biologic drugs that typically require injections. Commercializing such a breakthrough but complex technology requires significant investment. The chart below shows how the company is funding its costly clinical trials.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Rani Therapeutics
Rani Therapeutics is developing a revolutionary technology—a robotic capsule for the oral delivery of biologic drugs. This chart shows how much debt the company is raising to finance this futuristic but expensive development. High debt is a bet on a complete revolution in pharmacology, and failure will mean collapse.
Market segment debt to market segment book capitalization - Pharma other
Rani Therapeutics has developed a unique "robotic pill" technology for the oral delivery of biologic drugs typically administered by injection. The chart shows the sector's debt burden, helping to understand how the company is financing its revolutionary and capital-intensive technology, which could change the way drugs are delivered.
Debt to book value of all companies in the market
Rani Therapeutics Holdings has developed a revolutionary "robotic pill" technology for the oral delivery of biologics. For such an innovative company, the overall financial environment, shown in this chart, is critical. Access to venture capital for commercializing this breakthrough technology is directly dependent on market sentiment.
P/E of the company, segment and market as a whole
P/E - Rani Therapeutics
For Rani Therapeutics, a company that developed a "robotic pill" for drug delivery, this chart reflects faith in its revolutionary technology. High values indicate hopes that its platform will enable the oral administration of drugs currently available only as injections, opening up a huge market.
P/E of the market segment - Pharma other
This chart shows the average price-to-earnings ratio for the biotech sector, where Rani Therapeutics is an innovator. The industry's very high valuation reflects a belief in breakthrough technologies. This metric provides context for assessing how revolutionary the market considers Rani's "robo-pill" technology.
P/E of the market as a whole
Rani Therapeutics has developed a revolutionary "robotized pill" technology that enables the oral delivery of large drug molecules (such as insulin), replacing injections. This chart illustrates risk appetite in biotech. It helps understand whether the market believes Rani can transform the delivery of an entire class of drugs, and how this enormous, yet risky, potential is valued.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Rani Therapeutics
Rani Therapeutics has developed a revolutionary technology—a robotic capsule for the oral delivery of biologic drugs (such as insulin), which can currently only be administered by injection. This chart shows how much analysts believe this futuristic technology will become a reality and transform the pharmaceutical market.
%20P%2FE%20Rani%20Therapeutics&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Rani-Therapeutics&v=1772670753751 "Chart of the company's future (projected) P/E Rani Therapeutics")
Future (projected) P/E of the market segment - Pharma other
Rani Therapeutics has developed a revolutionary "robot pill" technology that enables the oral delivery of biologic drugs such as insulin. This graph shows its future profitability expectations, allowing us to assess how highly the market values its potential to transform the way many medications are taken.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-other&v=1772670753759 "Future (projected) P/E graph of the market segment - Pharma other")
Future (projected) P/E of the market as a whole
Rani Therapeutics has developed a revolutionary "robot pill" technology for orally delivering biologic drugs. This is a fundamental breakthrough. This chart, reflecting the market's risk appetite, shows how willing investors are to fund such bold ideas. Market optimism is critical for attracting capital to game-changing companies.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772670753760 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Rani Therapeutics
Rani Therapeutics Holdings has developed a unique "robotic pill" (RaniPill™) for the oral delivery of biologic drugs that typically require injections. Profitability is the future goal. This chart shows how much is being invested in this revolutionary technology, which could change the way millions of people take medications.
Profit of companies in the market segment - Pharma other
Rani Therapeutics has developed a revolutionary "robotic pill" technology, RaniPill™, which enables the oral delivery of biologic drugs (such as insulin), replacing injections. This graph reflects the enormous potential in a sector where solving the problem of oral delivery of large molecules could transform the lives of millions of patients and generate billions of dollars.
Overall market profit
Rani Therapeutics has developed an innovative "robotic pill" technology for orally delivering biologic drugs. Commercializing such a platform requires significant investment. This graph, reflecting market sentiment, influences the willingness of investors and large pharmaceutical companies to invest in revolutionary but risky technologies.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Rani Therapeutics
Rani Therapeutics has developed a revolutionary "robotic pill" technology that enables the oral delivery of biologic drugs (usually administered by injection). This chart summarizes analyst forecasts, betting on the success of this breakthrough technology and its potential to transform pharmaceuticals.
%20profit%20of%20the%20company%20Rani%20Therapeutics&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Rani-Therapeutics&v=1772670753797 "Graph of future (projected) profit of the company Rani Therapeutics")
Future (predicted) profit of companies in the market segment - Pharma other
Rani Therapeutics has developed a revolutionary "robotic pill" technology, RaniPill™, which enables the oral delivery of biologic drugs (such as insulin), replacing injections. This graph shows profitability projections for the biotech sector. It reflects the enormous potential of these technologies to revolutionize the way we administer complex medications.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-other&v=1772670753801 "Graph of future (predicted) profits of companies in a market segment - Pharma other")
Future (predicted) profit of the market as a whole
Rani Therapeutics Holdings has developed an innovative "robotic pill" technology for the oral delivery of biologic drugs. Commercializing this breakthrough technology requires significant investment. This chart, reflecting market sentiment, influences investor willingness to finance long-term, capital-intensive pharmaceutical projects.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772670753809 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Rani Therapeutics
Rani Therapeutics has developed a robotic pill for delivering biologics. This chart shows the huge premium the market is paying for its technology. This high price reflects the potential of its platform to revolutionize drug administration, replacing injections with pills.
P/S market segment - Pharma other
Rani Therapeutics Holdings has developed a robotic capsule for the oral delivery of biologics such as insulin. This chart shows the average revenue estimate in the biotech sector. It helps us estimate the premium investors are placing on the potential of Rani's revolutionary technology, which could replace injections with pills.
P/S of the market as a whole
Rani Therapeutics has developed a revolutionary "robotic pill" technology, RaniPill™, which delivers biologic drugs (such as insulin) orally instead of by injection. This chart, showing the valuation of companies with actual revenue, highlights the enormous expectations investors have for breakthrough technologies that have the potential to transform medicine.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Rani Therapeutics
Rani Therapeutics has developed a revolutionary "robotic" capsule that enables the oral delivery of biologic drugs (usually administered by injection). This chart reflects investor confidence in this technology. The valuation is based on the enormous potential for future revenue from licensing this platform to major pharmaceutical companies.
%20P%2FS%20Rani%20Therapeutics&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Rani-Therapeutics&v=1772670753821 "The graph of the company's future (projected) P/S Rani Therapeutics")
Future (projected) P/S of the market segment - Pharma other
Rani Therapeutics has developed a revolutionary "robot pill" technology that can deliver biologic drugs (such as insulin) orally, replacing injections. This chart shows how investors view this breakthrough technology compared to the pharmaceutical industry.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20other&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-other&v=1772670753829 "Future (projected) P/S market segment graph - Pharma other")
Future (projected) P/S of the market as a whole
Rani Therapeutics has developed a revolutionary "robotized pill" technology for the oral delivery of biologic drugs, currently administered only by injection. This schedule, reflecting investor appetite for breakthrough technologies, is critical for Rani. Market optimism is essential to fund the development of this platform, which has the potential to change the way many medications are administered.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772670753831 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Rani Therapeutics
Rani Therapeutics has developed a revolutionary "robotic pill" technology, RaniPill™, which enables the oral delivery of biologic drugs (such as insulin). This chart reflects revenue from strategic partnerships with major pharmaceutical companies. It demonstrates the financial support for this breakthrough technology, which has the potential to change the way drugs are administered.
Sales of companies in the market segment - Pharma other
Rani Therapeutics Holdings has developed a revolutionary "robotic pill" technology, RaniPill™, for the oral delivery of biologic drugs that typically require injections. The company's business is segmented by various drug development programs. This chart shows the financial flows associated with one of these innovative projects.
Overall market sales
Rani Therapeutics has developed a revolutionary "robotic pill" technology that enables the oral delivery of biologic drugs (usually administered by injection). If successful, this technology could radically change the treatment of many chronic diseases. It is an example of a breakthrough innovation that creates an entirely new market.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Rani Therapeutics
Rani Therapeutics has developed a revolutionary "robotic pill" technology, RaniPill™, which allows for the oral delivery of biologic drugs (such as insulin) instead of injections. Future sales projections suggest that its platform will become a new standard for large-molecule drug delivery, fundamentally changing the treatment of many diseases.
%20sales%20of%20the%20company%20Rani%20Therapeutics&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Rani-Therapeutics&v=1772670753844 "Schedule of future (projected) sales of the company Rani Therapeutics")
Future (projected) sales of companies in the market segment - Pharma other
Rani Therapeutics has developed a unique "robotic pill" technology that enables the oral delivery of injectable drugs. This graph reflects expectations for the entire pharmaceutical sector. It helps assess the potential of new drug delivery systems and the demand analysts predict for more patient-friendly therapies.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-other&v=1772670753845 "Schedule of future (projected) sales of companies in the market segment - Pharma other")
Future (projected) sales of the market as a whole
Rani Therapeutics has developed an innovative "robo-capsule" for the oral delivery of biologics. Its success depends on investments and partnerships with major pharmaceutical companies. This chart of overall sales forecasts reflects market sentiment, which influences the willingness of investors and pharma giants to invest in breakthrough technologies.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772670753848 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Rani Therapeutics
Rani Therapeutics Holdings has developed a revolutionary "robotic pill" technology (RaniPill™), which enables the oral delivery of biologic drugs. This chart reflects its financial position at the R&D stage, where massive investments in this breakthrough technology are the foundation for the future transformation of the pharmaceutical market.
Market segment marginality - Pharma other
Rani Therapeutics has developed a unique "robotic pill" technology that enables the oral delivery of biologic drugs (such as insulin). The effectiveness of their platform could revolutionize pharmaceuticals. The graph shows their operating costs as they pursue this ambitious goal.
Market marginality as a whole
Rani Therapeutics has developed an innovative "robotic pill" technology that enables the oral delivery of biologic drugs (usually administered by injection). This graph illustrates the profitability of traditional pharmaceuticals, but for RANI, this breakthrough technology, which could free millions of patients from injections, is the key to creating enormous value.
Employees in the company, segment and market as a whole
Number of employees in the company Rani Therapeutics
Rani Therapeutics has developed a revolutionary "robotic pill" technology for orally delivering injectable medications. This graph shows the team of engineers and scientists. The size of this team reflects the enormous investment in R&D required to bring such a breakthrough medical technology to market.
Share of the company's employees Rani Therapeutics within the market segment - Pharma other
Rani Therapeutics has developed a revolutionary "robo-pill" that can deliver biologic drugs (such as insulin) orally, replacing injections. Commercializing such a breakthrough technology requires a large team. This chart shows their human investment in transforming the way people take medications.
Number of employees in the market segment - Pharma other
Rani Therapeutics has developed a revolutionary robotic capsule for the oral delivery of biologics such as insulin. This graph reflects the pharmaceutical industry's employment. The growing number of scientists in the field of drug delivery indicates the search for solutions to the "holy grail"—converting injectables into tablets, the goal of Rani's technology.
Number of employees in the market as a whole
Rani Therapeutics has developed a robotic drug delivery pill. This is a revolution in biopharmaceuticals. Its growth depends on partnerships with major pharmaceutical companies and technology approval. This graph shows the current reality, but Rani is creating the future, and its success depends on innovation.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Rani Therapeutics (RANI)
Rani Therapeutics Holdings, Inc. has developed a robotic capsule technology for the oral delivery of biologics. This is a revolution in pharmaceuticals. The enormous market capitalization per employee in this chart reflects investors' faith in the breakthrough potential of this technology, created by an elite team of engineers and scientists.
%20of%20the%20company%20Rani%20Therapeutics%20(RANI)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Rani-Therapeutics-RANI&v=1772670753912 "Chart of market capitalization per employee (in thousands of dollars) of the company Rani Therapeutics (RANI)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma other
Rani Therapeutics Holdings is developing a revolutionary "robotic pill" technology for the oral delivery of biologics. This metric reflects how highly the market values their breakthrough platform and potential to transform pharmaceuticals. It's a pure assessment of intellectual capital and future prospects.
%20by%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-other&v=1772670753918 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma other")
Market capitalization per employee (in thousands of dollars) for the overall market
Rani Therapeutics has developed a revolutionary "robotic pill" technology that can deliver injectable (biological) drugs orally. This could change the way many diseases are treated. The chart illustrates the enormous potential the market sees in this breakthrough medical technology.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772670753922 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Rani Therapeutics (RANI)
Rani Therapeutics has revolutionized drug delivery. They developed a "robotic pill" (RaniPill™) that can deliver injectable drugs (like insulin) orally. They are a clinical-stage R&D company. This negative graph shows how much capital is burned per engineer and scientist to commercialize this futuristic but complex medical technology.
%20Chart%20Rani%20Therapeutics%20(RANI)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Rani-Therapeutics-RANI&v=1772670753931 "Company Profit Per Employee (in thousands of dollars) Chart Rani Therapeutics (RANI)")
Profit per employee (in thousands of dollars) in the market segment - Pharma other
Rani Therapeutics is a biotech company that has developed the "RaniPill" robotic capsule for the oral delivery of biologics such as insulin. This breakthrough technology requires an elite team of engineers and scientists. This graph shows the value they generate, which serves as an indicator of their potential compared to the overall pharmaceutical industry.
%20in%20the%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-other&v=1772670753935 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma other")
Profit per employee (in thousands of dollars) for the market as a whole
Rani Therapeutics (RANI) is developing a "robotic" capsule for the oral delivery of biologics (such as insulin). It is a revolutionary MedTech/BioTech company in the R&D stage. Its negative earnings per employee reflects the enormous investment in its team of engineers and scientists trying to commercialize this futuristic technology.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772670753944 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Rani Therapeutics (RANI)
Rani Therapeutics has developed an innovative "robotic pill" technology for the oral delivery of biologic drugs. Currently in the clinical stage, it has no sales revenue. This graph will eventually reveal whether its revolutionary technology can transform the pharmaceutical market.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Rani-Therapeutics-RANI&v=1772670753948 "Sales chart per company employee Rani Therapeutics (RANI)")
Sales per employee in the market segment - Pharma other
Rani Therapeutics is a biotech company that has developed a "robo-pill" (RaniPill) that can deliver injectable medications (like insulin) orally. This is a revolutionary technology. This chart compares revenue per employee (R&D) to the industry average, reflecting the productivity of their unique delivery platform.
Sales per employee for the market as a whole
Rani Therapeutics (RANI) is a biotech company that has developed the "robo-pill" (RaniPill)—a capsule capable of delivering injectable medications (like insulin) orally. This is an R&D platform. The company has no commercial revenue. This chart will reflect $0 or partnership revenue, as these are in the clinical trials stage.
Short shares by company, segment and market as a whole
Shares shorted by company Rani Therapeutics (RANI)
Rani Therapeutics (RANI) is developing a "robotic" pill capable of delivering injectable drugs (like insulin) directly into the intestinal wall. It sounds like science fiction. This chart shows the number of investors who consider this technology overly complex, expensive, and unlikely to be commercially successful.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Rani-Therapeutics-RANI&v=1772670753988 "Short Shares Chart for the Company Rani Therapeutics (RANI)")
Shares shorted by market segment - Pharma other
Rani Therapeutics is a biotech company that developed the RaniPill, a robotic capsule capable of delivering injectable medications (like insulin) orally. This chart shows the odds against the drug delivery sector, reflecting investors' extreme skepticism that this futuristic technology can be safe and effective.
Shares shorted by the overall market
Rani Therapeutics is developing "robotic" capsules for delivering biologics to the intestines. This is futuristic biotech. This chart reflects the overall market pessimism. When investors are afraid, they don't invest in "science fiction." They see the enormous R&D costs and don't believe this complex technology will pay off.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Rani Therapeutics (RANI)
Rani Therapeutics is a biotech with a revolutionary idea for a "robo-pill" (RaniPill) that could deliver injectable medications (like insulin) orally. It's a risky bet on a breakthrough. This chart measures the hype surrounding their technology, showing "overheating" (above 70) on positive data or "oversold" (below 30) on slowdowns.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Rani-Therapeutics-RANI&v=1772670753997 "RSI 14 indicator chart for the company's stock Rani Therapeutics (RANI)")
RSI 14 Market Segment - Pharma other
Rani Therapeutics is a biotech company that has revolutionized drug delivery. Its "RaniPill" is a robotic capsule that allows for the oral administration of injectable medications (like insulin). This chart shows the overall sentiment in the specialty pharmaceutical sector. It helps us understand whether RANI's momentum is driven by its unique technology or is a general "wave" across the industry.
RSI 14 for the overall market
Rani Therapeutics (RANI) is a biotech company. Like everything in its sector, it's critically dependent on this schedule. Market euphoria offers the potential to easily raise hundreds of millions of dollars for research. Market panic risks running out of money before its breakthrough technologies reach patients.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast RANI (Rani Therapeutics)
Rani Therapeutics is a biotech company that has developed a "robotic" capsule (RaniPill) that delivers injectable medications (like insulin) orally. This chart shows the average target price. Analysts' forecasts are based on the success of clinical trials of this revolutionary delivery platform.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-RANI-Rani-Therapeutics&v=1772670754007 "A chart showing analyst consensus forecasts for the expected stock price. RANI (Rani Therapeutics)")
The difference between the consensus estimate and the actual stock price RANI (Rani Therapeutics)
Rani Therapeutics is a breakthrough in biotech. The company has developed a "robo-pill" (RaniPill) that can deliver injectable drugs (like Humira) orally. This chart shows how the current share price differs from the "fair" value predicted by analysts, reflecting their faith in this revolutionary technology.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-RANI-Rani-Therapeutics&v=1772670754022 "A chart showing the difference between the consensus forecast and the actual stock price. RANI (Rani Therapeutics)")
Analyst consensus forecast for stock prices by market segment - Pharma other
Rani Therapeutics is a "high-tech pill." The company has developed a "robotic" capsule (RaniPill) that "injects" biologics (like Humira) directly into the intestinal wall. This chart shows the general expectations of analysts in the pharmaceutical sector. It reflects whether experts believe in a revolution in the "oral" delivery of complex drugs.
Analysts' consensus forecast for the overall market share price
Rani Therapeutics is a biotech company that has developed a "robotic" capsule (RaniPill) that allows injectable drugs (biologics) to be administered as a pill. This chart shows the overall market "risk appetite." For Rani, a company with a revolutionary delivery platform, overall market optimism (risk appetite) is critical for R&D funding.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Rani Therapeutics
Rani Therapeutics is a robotic pill. They're developing RaniPill—a futuristic capsule you swallow that, via a microneedle, delivers large drugs (like Humira), currently only available through injection, into your intestines. This graph is a clear indicator of their R&D, reflecting their progress in this sci-fi technology.
AKIMA Market Segment Index - Pharma other
Rani Therapeutics (RANI) is revolutionizing the pharmaceutical industry with its RaniPill, a robotic capsule designed for the oral delivery of injectable drugs (biologics) by inserting them into the intestinal wall. This chart shows the segment's average index, helping investors assess how this breakthrough technology compares to the industry average.
The AKIM Index for the overall market
Rani Therapeutics is a biotech company that has developed a "robotic pill" (RaniPill) for the oral delivery of biological drugs (instead of injections). This chart, which reflects the market average, is a backdrop. It helps assess how this breakthrough delivery technology compares to overall macroeconomic trends.
